Kamada (KMDA) CFO Orlev Chaime Receives Stock Option Awards

What Happened

• Orlev Chaime, Chief Financial Officer of Kamada Ltd. (KMDA), received three stock option awards (derivative grants) on August 27, 2026 covering 22,500; 90,000; and 90,000 ordinary shares — a total of 202,500 options. The Form 4 lists an acquisition price of $0.00 for each grant (derivative), and the reported dollar exercise prices were adjusted in connection with a special cash dividend declared August 17, 2026 (record date Aug 27, 2026). The grants are held by a trustee under the company’s 2011 Share Award Plan and vest in four equal annual installments (25% each anniversary of the grant).

Key Details

• Transaction date: August 27, 2026 (reported on Form 4 filed September 23, 2026 — filing appears late relative to the typical 2-business-day rule).
• Grants: 22,500; 90,000; 90,000 options (total 202,500).
• Form shows acquisition price $0.00 for each grant; footnotes indicate prior reported USD-equivalent exercise prices of $6.15, $6.19 and $7.61 were adjusted due to the special cash dividend (amounts are presented in USD based on Bank of Israel exchange rate).
• Vesting: 25% on each of the four anniversaries of the grant date.
• Held by trustee under the 2011 Share Award Plan (per footnote).
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Filing timeliness: filed Sept 23, 2026 for an Aug 27, 2026 transaction — appears to be a late Form 4 filing (investors should note potential reporting delay).

Context

• These are option grants (derivative awards), not open-market purchases or sales — they represent long-term incentive compensation and do not equal immediate share purchases. The options vest over four years, so they are retention/incentive awards rather than an immediate bullish purchase. The exercise-price adjustments reflect the company’s special cash dividend, per the form footnotes.